Article

AcuFocus introduces new surgical planning device

AcuFocus has launched a new diagnostic and surgical planning instrument designed to further optimize clinical outcomes for its corneal inlay (Kamra) and streamline the patient care process.

 

Irvine, CA-AcuFocus has launched a new diagnostic and surgical planning instrument designed to further optimize clinical outcomes for its corneal inlay (Kamra) and streamline the patient care process.

AcuFocus developed the device, AcuTarget HD, in collaboration with Visiometrics.

“By combining our science with AcuFocus’ inlay centration expertise, I believe we have jointly developed a technology that will simplify and streamline the inlay patient selection and care process,” said Jan Bonel, chief executive officer of Visiometrics.

The new device offers a broader range of functionality than its predecessor by combining five diagnostic tools into one state-of-the-art instrument to provide practices with new objective data to support patient selection, inlay centration, and postoperative management.

“We understood that by having more objective information, practitioners are able to make better, more informed decisions,” said Jim Mazzo, chief executive officer and executive chairman of AcuFocus. “Not only does the (device) provide a broader range of objective patient information, it does so quickly and reliably. We believe this advanced device will become an invaluable addition to a surgeon’s practice.”

The new device will be on display for the first time in the AcuFocus booth (#E01) at the 2013 European Society of Cataract and Refractive Surgeons in Amsterdam on Oct. 5 through 9.

 

 

For more articles in this issue of Ophthalmology Times eReport, click here.

 

 

 

To receive weekly clinical news and updates in ophthalmology, subscribe to the Ophthalmology Times eReport.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.